AAAAAA

   
Results: 1-10 |
Results: 10
How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?
Authors: Grover, SA Coupal, L Zowall, H Alexander, CM Weiss, TW Gomes, DRJ
Citation: Sa. Grover et al., How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?, DIABET CARE, 24(1), 2001, pp. 45-50
Stromelysin-1 regulates adipogenesis during mammary gland involution
Authors: Alexander, CM Selvarajan, S Mudgett, J Werb, Z
Citation: Cm. Alexander et al., Stromelysin-1 regulates adipogenesis during mammary gland involution, J CELL BIOL, 152(4), 2001, pp. 693-703
Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits
Authors: Klinowska, TCM Alexander, CM Georges-Labouesse, E Van der Neut, R Kreidberg, JA Jones, CJP Sonnenberg, A Streuli, CH
Citation: Tcm. Klinowska et al., Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits, DEVELOP BIO, 233(2), 2001, pp. 449-467
Use of simvastatin treatment in patients with combined hyperlipidemia in clinical practice
Authors: Vicari, RM Wan, GJ Aura, AM Alexander, CM Markson, LE Teutsch, SM
Citation: Rm. Vicari et al., Use of simvastatin treatment in patients with combined hyperlipidemia in clinical practice, ARCH FAM M, 9(9), 2000, pp. 898-905
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
Authors: Alexander, CM Reichsman, F Hinkes, MT Lincecum, J Becker, KA Cumberledge, S Bernfield, M
Citation: Cm. Alexander et al., Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice, NAT GENET, 25(3), 2000, pp. 329-332
Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors,and prevalence of coronary heart disease
Authors: Alexander, CM Landsman, PB Teutsch, SM
Citation: Cm. Alexander et al., Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors,and prevalence of coronary heart disease, AM J CARD, 86(9), 2000, pp. 897-902
Effect of lovastatin on cardiovascular resource utilization end costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Authors: Gotto, AM Boccuzzi, SJ Cook, JR Alexander, CM Roehm, JB Meyer, GS Clearfield, M Weis, S Whitney, E
Citation: Am. Gotto et al., Effect of lovastatin on cardiovascular resource utilization end costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS), AM J CARD, 86(11), 2000, pp. 1176-1181
Effect of simvastatin treatment on cardiovascular resource utilization in impaired pasting glucose and diabetes - Findings from the Scandinavian Simvastatin Survival Study
Authors: Herman, WH Alexander, CM Cook, JR Boccuzzi, SJ Musliner, TA Pedersen, TR Kjekshus, J Pyorala, K
Citation: Wh. Herman et al., Effect of simvastatin treatment on cardiovascular resource utilization in impaired pasting glucose and diabetes - Findings from the Scandinavian Simvastatin Survival Study, DIABET CARE, 22(11), 1999, pp. 1771-1778
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels - Subgroup analyses in the Scandinavian simvastatin survival study
Authors: Haffner, SM Alexander, CM Cook, TJ Boccuzzi, SJ Musliner, TA Pedersen, TR Kjekshus, J Pyorala, K
Citation: Sm. Haffner et al., Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels - Subgroup analyses in the Scandinavian simvastatin survival study, ARCH IN MED, 159(22), 1999, pp. 2661-2667
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease
Authors: Sueta, CA Chowdhury, M Boccuzzi, SJ Smith, SC Alexander, CM Londhe, A Lulla, A Simpson, RJ
Citation: Ca. Sueta et al., Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease, AM J CARD, 83(9), 1999, pp. 1303-1307
Risultati: 1-10 |